Zhendong Pharmacy(SZ:300158) Xin Lang Cai Jing·2025-09-17 07:02Company Overview - Shanxi Zhendong Pharmaceutical Co., Ltd. is located in Changzhi City, Shanxi Province, and was established on November 15, 1995. The company went public on January 7, 2011. Its main business includes the research, production, and sales of generic and innovative drugs related to oncology, hair, digestion, urology, and cardiovascular diseases, as well as a full industry chain for traditional Chinese medicine [2]. Financial Performance - For the first half of 2025, Zhendong Pharmaceutical achieved operating revenue of 1.457 billion yuan, a year-on-year decrease of 3.30%. The net profit attributable to the parent company was 7.9313 million yuan, down 74.13% year-on-year [2]. - The company has cumulatively distributed 3.372 billion yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3]. Stock Market Activity - As of September 17, Zhendong Pharmaceutical's stock price was 7.38 yuan per share, with a market capitalization of 7.419 billion yuan. The stock has increased by 70.83% year-to-date but has seen a decline of 4.28% in the last five trading days and 13.99% in the last 20 days [1]. - The company has appeared on the "Dragon and Tiger List" four times this year, with the most recent appearance on August 11, where it recorded a net purchase of 86.6539 million yuan [1]. Shareholder Information - As of June 30, 2025, the number of shareholders was 46,100, a decrease of 5.04% from the previous period. The average circulating shares per person increased by 5.31% to 21,777 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest, holding 7.9704 million shares, an increase of 5.0578 million shares from the previous period [3].